Difference between revisions of "Neuropathology tumours"

Jump to navigation Jump to search
→‎Ganglioglioma: update (WHO 2016 compatible)
(→‎Ganglioglioma: update (WHO 2016 compatible))
Line 409: Line 409:
:'''Not''' to be confused with ''[[ganglioneuroma]]''.
:'''Not''' to be confused with ''[[ganglioneuroma]]''.
====General====
====General====
*Grade I WHO mixed neuronal-glial tumour.
*Gangliolioma: Grade I WHO mixed neuronal-glial tumour (ICD-O code: 9505/1).
*ICD-O code: 9505/1 (Anaplastic ganglioglioma: 9505/3)
*Anaplastic ganglioglioma: Grade III (ICD-O: 9505/3)
*Rare.
*Rare (approx. 0.5% of all CNS tumors).
*Usu. temporal lobe.
*Usu. temporal lobe.
*Predominantly children (mean age: 9 years).
*Recognized as a cause of [[epilepsy]].<ref name=pmid12125968>{{Cite journal  | last1 = Im | first1 = SH. | last2 = Chung | first2 = CK. | last3 = Cho | first3 = BK. | last4 = Lee | first4 = SK. | title = Supratentorial ganglioglioma and epilepsy: postoperative seizure outcome. | journal = J Neurooncol | volume = 57 | issue = 1 | pages = 59-66 | month = Mar | year = 2002 | doi =  | PMID = 12125968 }}</ref>
*Recognized as a cause of [[epilepsy]].<ref name=pmid12125968>{{Cite journal  | last1 = Im | first1 = SH. | last2 = Chung | first2 = CK. | last3 = Cho | first3 = BK. | last4 = Lee | first4 = SK. | title = Supratentorial ganglioglioma and epilepsy: postoperative seizure outcome. | journal = J Neurooncol | volume = 57 | issue = 1 | pages = 59-66 | month = Mar | year = 2002 | doi =  | PMID = 12125968 }}</ref>
*Favourable prognosis (survival rates up to 97%)
**Insufficient data für anaplastic ganglioglioma.
====Macroscopic====
*Circumscribed lesion.
*Usu. contrast enhancing.
*Solid, but intracortical cysts may be present.
*Little mass effect.


====Microscopic====
====Microscopic====
Line 423: Line 433:
**Binucleated (very occassionally).
**Binucleated (very occassionally).
*Atypical glia.
*Atypical glia.
*Eosinophilic granular bodies.
*Calcification.
*Calcification.
*Prominent capillary network.
*Lymphocytic cuffing.
*Lymphocytic cuffing.
*May contain some reticulin.
*Glial component may resemble:
**Fibrillary astrocytoma.
**Oligodendroglioma.
**Pilocytic astrocytoma.
Anaplastic ganglioglioma:
Anaplastic ganglioglioma:
*Brisk mitotic activity
*Brisk mitotic activity
Line 436: Line 454:
*Glia:
*Glia:
**CD34+/-ve
**CD34+/-ve
*BRAF V600E +ve (approx. 25%, mainly ganglion cells).
====Molecular====
*BRAF V600E-mutated(approx. 25%).
*IDH1/2 wt.
*No 1p/19q codeletion.
*Usu. Chr. 7 gain.
*CDKN2A deletions in anaplastic ganglioglioma.


====DDx:====
====DDx:====
Line 441: Line 467:
*[[Oligodendroglioma]].
*[[Oligodendroglioma]].
*Trapped cortical neurons in diffuse astrocytoma.
*Trapped cortical neurons in diffuse astrocytoma.
*Papillary glioneuronal tumor.
*Dysembryoplastic neuroepithelial tumor.


====Images====
====Images====
Line 447: Line 475:
File:Ganglioglioma calcification.jpg | Calcification in ganglioglioma (WC/jensflorian)
File:Ganglioglioma calcification.jpg | Calcification in ganglioglioma (WC/jensflorian)
File:Ganglioglioma Cd34 x200.jpg | CD34 immunostain in ganglioglioma (WC/jensflorian)
File:Ganglioglioma Cd34 x200.jpg | CD34 immunostain in ganglioglioma (WC/jensflorian)
File:Anaplastic ganglioglioma HE.jpg | Pleomorphic ganglion cells in ganglioglioma (WC/jensflorian)
</gallery>
</gallery>
*[http://path.upmc.edu/cases/case142.html Ganglioglioma - case 1 (upmc.edu)].
*[http://path.upmc.edu/cases/case142.html Ganglioglioma - case 1 (upmc.edu)].
*[http://path.upmc.edu/cases/case282.html Ganglioglioma - case 2 (upmc.edu)].
*[http://path.upmc.edu/cases/case282.html Ganglioglioma - case 2 (upmc.edu)].


===Lhermitte-Duclos disease===
===Lhermitte-Duclos disease===
Account-creators
1,040

edits

Navigation menu